Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease

V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), E. Blinova (Chelyabinsk, Russian Federation), I. Grebneva (Chelyabinsk, Russian Federation), O. Rodionova (Chelyabinsk, Russian Federation)

Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Session: COPD treatment: cardiovascular, oxygen and vaccination studies
Session type: Thematic Poster
Number: 2467
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), E. Blinova (Chelyabinsk, Russian Federation), I. Grebneva (Chelyabinsk, Russian Federation), O. Rodionova (Chelyabinsk, Russian Federation). Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease. 2467

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006

Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007

Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006

Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005

Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008



Rate of flu vaccination in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004

Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Pneumococcal vaccination coverage in Spanish patients with chronic obstructive pulmonary disease (COPD). Result of the EPIDEPOC study
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004

Should chronic obstructive pulmonary disease patients must be vaccinated?
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013

Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019


Hospitalization for influenza among patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021


Results of vaccination against pneumococcal infection in patients with chronic heart failure
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003


Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020


Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016